Description: Parx Materials N.V. engages in the manufacture and sale of antibacterial/antimicrobial plastics worldwide. The company offers its products for food contact applications and food packaging; medical devices and implants; textiles; pipes and drainages; and anti-fouling and hygiene applications, as well as to prevent mold and material deterioration; and biofilm formation. It holds a patented technology under the Saniconcentrate name. The company was formerly known as Parx Plastics N.V. and changed its name to Parx Materials N.V. in January 2020. Parx Materials N.V. was incorporated in 2012 and is headquartered in Rotterdam, the Netherlands.
Home Page: www.parxmaterials.com
Het Industriegebouw
Rotterdam,
3011 KD
Netherlands
Phone:
31 10 340 0095
Officers
| Name | Title |
|---|---|
| Mr. Michael van der Jagt | Founder, CEO & Director |
| Mr. Michele Fiori | Founder, CTO & Director |
Exchange: PA
Country: FR
Currency: Euro (€)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 31.3158 |
| Price-to-Book MRQ: | 5.0764 |
| Price-to-Sales TTM: | 128.2074 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 0 |